A study on gut health, pelvic side effects, and ozone therapy
Part of Injuries & trauma clinical trials.
This study looks at the bacteria in your gut (gut microbiome) to see how it is affected by pelvic side effects from cancer treatment, and whether ozone therapy might help. It compares patients who have chronic pelvic side effects and are treated with ozone (cases) to those who do not have these side effects (controls).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman 18 years or older.
- You have been diagnosed with a gynecological cancer (any type or stage).
- You have had radiation therapy and/or chemotherapy in the past.
- You are willing to sign a consent form to participate in the study.
- For the ozone treatment group: you have had moderate or severe pelvic side effects for at least 3 months that did not get better with usual treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a pre-rehabilitation (pre-hab) program to help women stay stronger before and during pelvic radiation for certain cancers. The goal is to see if it improves quality of life and reduces treatment side effects.
This trial tests whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can improve symptoms and reduce inflammation in people with bladder damage from past pelvic radiation. It compares patients with radiation cystitis to those without it.
This study is looking at whether ozone therapy can help relieve chronic pelvic pain caused by gynecological cancer treatments like radiation and chemotherapy. It aims to understand how the treatment works at a molecular level.
This study looks at how bacteria in your gut (microbiome) might be linked to nerve pain from chemotherapy. It is for people who are already in the OzoParQT trial and will provide a stool sample to help understand this connection.
This trial tests an oral probiotic (a mix of 5 good bacteria) to see if it can reduce stomach and bowel side effects from pelvic radiation. It may help people undergoing radiation for certain pelvic cancers.
This study looks at how immune checkpoint inhibitors (a type of immunotherapy) affect the gut microbiome and ovarian function in women with cancer. It may help understand why some women have different fertility outcomes after treatment.
Hear when a new Radiation Toxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.